Skip to content
GenoLensGenoLens

GMPPA

Chr 2q35

GDP-mannose pyrophosphorylase A

MANE:
ENST00000313597.10

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Congenital disorders of glycosylation

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Familial dysautonomia

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Triple A syndrome

    0.79
  • hereditary disease

    0.41
  • triple-A syndrome

    0.37
  • Intellectual disability - alacrima - achalasia

    0.37
  • chromosomal instability with tissue-specific radiosensitivity

    0.34
  • smoking initiation

    0.11
  • amyotrophic lateral sclerosis

    0.08
  • Congenital myasthenic syndromes

    0.08
  • congenital myasthenic syndromes with glycosylation defect

    0.07
  • genetic developmental and epileptic encephalopathy

    0.07

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Mannose-1-phosphate guanylyltransferase regulatory subunit alpha

Regulatory subunit of the GMPPA-GMPPB mannose-1-phosphate guanylyltransferase complex; reduces the catalytic activity of GMPPB when part of the complex (PubMed:24035193, PubMed:33986552). Mediates allosteric feedback inhibition of GMPPB catalytic activity upon binding GDP-alpha-D-mannose (PubMed:24035193, PubMed:33986552). Together with GMPPB regulates GDP-alpha-D-mannose levels (PubMed:33986552)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.